Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

ClinicalTrials.gov ID: NCT00121667

Public ClinicalTrials.gov record NCT00121667. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial to Evaluate the Efficacy and Safety of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone"

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone

Study identification

NCT ID
NCT00121667
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,462 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 77 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Sep 30, 2006
Completion
Jan 31, 2010
Last update posted
Apr 28, 2015

2005 – 2010

United States locations

U.S. sites
95
U.S. states
32
U.S. cities
95
Facility City State ZIP Site status
Local Institution Anniston Alabama
Local Institution Birmingham Alabama
Local Institution Calera Alabama
Local Institution Haleyville Alabama
Local Institution Mesa Arizona
Local Institution Phoenix Arizona
Local Institution Jonesboro Arkansas
Local Institution Little Rock Arkansas
Local Institution Sherwood Arkansas
Local Institution Encino California
Local Institution Fountain Valley California
Local Institution Fresno California
Local Institution Los Angeles California
Local Institution Mission Viejo California
Local Institution Northridge California
Local Institution Orange California
Local Institution Roseville California
Local Institution Sacramento California
Local Institution Spring Valley California
Local Institution Tustin California
Local Institution Castle Rock Colorado
Local Institution Colorado Springs Colorado
Local Institution Denver Colorado
Local Institution Golden Colorado
Local Institution Loveland Colorado
Local Institution Altamonte Springs Florida
Local Institution Chipley Florida
Local Institution Cocoa Beach Florida
Local Institution Coral Gables Florida
Local Institution Fort Lauderdale Florida
Local Institution Jacksonville Florida
Local Institution Kissimmee Florida
Local Institution Marianna Florida
Local Institution Miami Florida
Local Institution New Port Richey Florida
Local Institution Ocala Florida
Local Institution Tallahassee Florida
Local Institution Tampa Florida
Local Institution Decatur Georgia
Local Institution Chicago Illinois
Local Institution Vernon Hills Illinois
Local Institution Elkhart Indiana
Local Institution Lafayette Indiana
Local Institution Iowa City Iowa
Local Institution Waterloo Iowa
Local Institution Topeka Kansas
Local Institution Lexington Kentucky
Local Institution Munfordville Kentucky
Local Institution New Orleans Louisiana
Local Institution West Monroe Louisiana
Local Institution Baltimore Maryland
Local Institution Chester Maryland
Local Institution Prince Frederick Maryland
Local Institution Boston Massachusetts
Local Institution Kansas City Missouri
Local Institution St Louis Missouri
Local Institution Kalispell Montana
Local Institution Omaha Nebraska
Local Institution Las Vegas Nevada
Local Institution Toms River New Jersey
Local Institution Albuquerque New Mexico
Local Institution Charlotte North Carolina
Local Institution Greensboro North Carolina
Local Institution Morehead City North Carolina
Local Institution Salisbury North Carolina
Local Institution Sparta North Carolina
Local Institution Wilmington North Carolina
Local Institution Winston-Salem North Carolina
Local Institution Athens Ohio
Local Institution Columbus Ohio
Local Institution Lyndhurst Ohio
Local Institution Oklahoma City Oklahoma
Local Institution Tulsa Oklahoma
Local Institution Eugene Oregon
Local Institution Portland Oregon
Local Institution Carlisle Pennsylvania
Local Institution Langhorne Pennsylvania
Local Institution Levittown Pennsylvania
Local Institution Philadelphia Pennsylvania
Local Institution Pittsburgh Pennsylvania
Local Institution Charleston South Carolina
Local Institution Duncan South Carolina
Local Institution Bristol Tennessee
Local Institution Austin Texas
Local Institution Bryan Texas
Local Institution Carrollton Texas
Local Institution Dallas Texas
Local Institution Houston Texas
Local Institution San Antonio Texas
Local Institution Temple Texas
Local Institution Salt Lake City Utah
Local Institution Hampton Virginia
Local Institution Virginia Beach Virginia
Local Institution Olympia Washington
Local Institution Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00121667, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00121667 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →